Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors NCT00006036 Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 Years Canadian Cancer Trials Group View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer NCT02177838 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer NCT00023959 Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
hydroxyurea
fluorouracil
bevacizumab
radiation thera...
filgrastim
laboratory biom...
18 Years - National Cancer Institute (NCI) View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer NCT00963326 Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI) View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function NCT00002901 Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center View Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer NCT00963326 Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI) View Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery NCT00041171 Adult Solid Tum...
Breast Cancer
Head and Neck C...
Kidney and Urin...
Male Reproducti...
Thorax and Resp...
Hypericum perfo...
docetaxel
placebo
18 Years - 120 Years Alliance for Clinical Trials in Oncology View Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00089362 Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer NCT00897793 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center View Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00721513 Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 Years Wake Forest University Health Sciences View Docetaxel in Treating Patients With Solid Tumors NCT00003565 Bladder Cancer
Breast Cancer
Head and Neck C...
Lung Cancer
Unspecified Adu...
docetaxel
18 Years - Alliance for Clinical Trials in Oncology View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy NCT01728480 Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute View Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer NCT02177838 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy NCT02123511 Mucositis
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Lympho...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Lymph...
Stage IVA Mucoe...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Lymph...
Stage IVB Mucoe...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Lymph...
Stage IVC Mucoe...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
acetylcysteine
placebo
quality-of-life...
questionnaire a...
18 Years - Mayo Clinic View Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy NCT00898430 Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center View Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck NCT00720304 Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer NCT00293462 Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco View Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429 Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center View Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00049283 Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract NCT00765440 Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 Years Centre Antoine Lacassagne View Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors NCT00006036 Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 Years Canadian Cancer Trials Group View Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00721513 Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 Years Wake Forest University Health Sciences View Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer NCT00049283 Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer NCT01155609 Mucositis
Oral Complicati...
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
quality-of-life...
management of t...
L-lysine
18 Years - University of Washington View Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer NCT00002476 Head and Neck C...
bleomycin sulfa...
fluorouracil
leucovorin calc...
methotrexate
vincristine sul...
low-LET cobalt-...
low-LET photon ...
radiation thera...
18 Years - National Cancer Institute (NCI) View Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy NCT01210872 Head and Neck C...
questionnaire a...
quality-of-life...
standard follow...
18 Years - 70 Years National Cancer Institute (NCI) View Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck NCT00906360 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
sunitinib malat...
pharmacological...
3-dimensional c...
cetuximab
18 Years - National Cancer Institute (NCI) View GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer NCT00293462 Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco View Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer NCT00068497 Anaplastic Thyr...
Insular Thyroid...
Metastatic Para...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Parat...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Stage III Folli...
Stage III Papil...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IIIB Non-...
Stage IV Lympho...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Esthe...
Stage IVA Folli...
Stage IVA Inver...
Stage IVA Lymph...
Stage IVA Midli...
Stage IVA Mucoe...
Stage IVA Papil...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Esthe...
Stage IVB Folli...
Stage IVB Inver...
Stage IVB Lymph...
Stage IVB Midli...
Stage IVB Mucoe...
Stage IVB Papil...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Esthe...
Stage IVC Folli...
Stage IVC Inver...
Stage IVC Lymph...
Stage IVC Midli...
Stage IVC Mucoe...
Stage IVC Papil...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Thryoid Gland N...
Thyroid Gland M...
Tongue Cancer
Untreated Metas...
gefitinib
- National Cancer Institute (NCI) View Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy NCT01728480 Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute View Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract NCT00765440 Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 Years Centre Antoine Lacassagne View Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer NCT00616590 Fatigue
Head and Neck C...
Psychosocial Ef...
Sleep Disorders
medical chart r...
questionnaire a...
fatigue assessm...
quality-of-life...
21 Years - Vanderbilt University View Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer NCT00898300 Head and Neck C...
biologic sample...
biopsy
18 Years - Radiation Therapy Oncology Group View Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer NCT00017511 Head and Neck C...
Oral Complicati...
Radiation Toxic...
cevimeline hydr...
18 Years - Daiichi Sankyo View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Family Quality of Life Among Families With a Member Who is a Cancer Patient NCT00544336 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
Solid Tumor
questionnaire a...
survey administ...
quality-of-life...
21 Years - Vanderbilt-Ingram Cancer Center View Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer NCT00090337 Head and Neck C...
Pain
acupuncture the...
standard follow...
- Memorial Sloan Kettering Cancer Center View Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck NCT01192815 Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
erlotinib hydro...
intensity-modul...
pharmacogenomic...
gene expression...
3-dimensional c...
biopsy
pharmacological...
laboratory biom...
questionnaire a...
enzyme-linked i...
polymorphism an...
18 Years - 70 Years Case Comprehensive Cancer Center View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck NCT00720304 Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center View Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429 Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center View Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia NCT00503776 Dysphagia
Head and Neck C...
Mucositis
Xerostomia
exercise interv...
amifostine trih...
therapeutic die...
21 Years - Vanderbilt-Ingram Cancer Center View Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck NCT00720304 Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center View RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer NCT00956007 Head and Neck C...
cetuximab
intensity-modul...
18 Years - Radiation Therapy Oncology Group View Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer NCT02048020 Human Papilloma...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IV Verruc...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
paclitaxel
carboplatin
intensity-modul...
quality-of-life...
19 Years - Jonsson Comprehensive Cancer Center View Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck NCT00720304 Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center View Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer NCT00090337 Head and Neck C...
Pain
acupuncture the...
standard follow...
- Memorial Sloan Kettering Cancer Center View Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00089362 Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer NCT00068497 Anaplastic Thyr...
Insular Thyroid...
Metastatic Para...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Parat...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Stage III Folli...
Stage III Papil...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IIIB Non-...
Stage IV Lympho...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Esthe...
Stage IVA Folli...
Stage IVA Inver...
Stage IVA Lymph...
Stage IVA Midli...
Stage IVA Mucoe...
Stage IVA Papil...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Esthe...
Stage IVB Folli...
Stage IVB Inver...
Stage IVB Lymph...
Stage IVB Midli...
Stage IVB Mucoe...
Stage IVB Papil...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Esthe...
Stage IVC Folli...
Stage IVC Inver...
Stage IVC Lymph...
Stage IVC Midli...
Stage IVC Mucoe...
Stage IVC Papil...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Thryoid Gland N...
Thyroid Gland M...
Tongue Cancer
Untreated Metas...
gefitinib
- National Cancer Institute (NCI) View Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer NCT00006799 Anorexia
Cachexia
Head and Neck C...
Quality of Life
megestrol aceta...
quality-of-life...
18 Years - 120 Years Wake Forest University Health Sciences View Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy NCT01164566 Stage I Adenoid...
Stage I Mucoepi...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Mucoep...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Mucoe...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Mucoep...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
endoscopic proc...
questionnaire a...
18 Years - Wake Forest University Health Sciences View Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck NCT01473784 Recurrent Adeno...
Recurrent Mucoe...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage I Adenoid...
Stage I Mucoepi...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Mucoep...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Mucoe...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Mucoe...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Mucoe...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Mucoe...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
transoral robot...
quality of life...
18 Years - Ohio State University Comprehensive Cancer Center View Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract NCT00765440 Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 Years Centre Antoine Lacassagne View Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer NCT00004065 Bladder Cancer
Breast Cancer
Colorectal Canc...
Gastric Cancer
Head and Neck C...
Kidney Cancer
Leukemia
Lung Cancer
Melanoma (Skin)
Ovarian Cancer
Prostate Cancer
Unspecified Adu...
tanespimycin
18 Years - Memorial Sloan Kettering Cancer Center View TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck NCT01334177 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
TLR8 agonist VT...
cetuximab
laboratory biom...
pharmacogenomic...
18 Years - University of Washington View Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants NCT00898638 Head and Neck C...
biologic sample...
medical chart r...
18 Years - Vanderbilt University Medical Center View Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer NCT00820248 Head and Neck C...
panitumumab
cisplatin
3-dimensional c...
accelerated rad...
intensity-modul...
18 Years - Canadian Cancer Trials Group View Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy NCT00898430 Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center View Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer NCT00492089 Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI) View Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy NCT01674374 Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Tongue Cancer
placebo
quality-of-life...
questionnaire a...
Vaccinium myrti...
18 Years - Roswell Park Cancer Institute View Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer NCT00616590 Fatigue
Head and Neck C...
Psychosocial Ef...
Sleep Disorders
medical chart r...
questionnaire a...
fatigue assessm...
quality-of-life...
21 Years - Vanderbilt University View Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer NCT00023959 Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
hydroxyurea
fluorouracil
bevacizumab
radiation thera...
filgrastim
laboratory biom...
18 Years - National Cancer Institute (NCI) View Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer NCT00492089 Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI) View Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer NCT00101348 Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Colon...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Pancr...
Recurrent Recta...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Pancr...
Stage III Recta...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Non-...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
erlotinib hydro...
cetuximab
bevacizumab
laboratory biom...
18 Years - National Cancer Institute (NCI) View Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer NCT00415025 Head and Neck C...
Long-term Effec...
Oral Complicati...
Radiation Toxic...
adjuvant therap...
management of t...
quality-of-life...
intensity-modul...
18 Years - 120 Years University of Wisconsin, Madison View Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants NCT00898638 Head and Neck C...
biologic sample...
medical chart r...
18 Years - Vanderbilt University Medical Center View